nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—ACE—chronic obstructive pulmonary disease	0.482	1	CbGaD
Quinapril—Labetalol—Formoterol—chronic obstructive pulmonary disease	0.191	0.5	CrCrCtD
Quinapril—Labetalol—Arformoterol—chronic obstructive pulmonary disease	0.191	0.5	CrCrCtD
Quinapril—ACE—pulmonary artery—chronic obstructive pulmonary disease	0.00622	0.501	CbGeAlD
Quinapril—ACE—respiratory system—chronic obstructive pulmonary disease	0.00105	0.0843	CbGeAlD
Quinapril—ACE—connective tissue—chronic obstructive pulmonary disease	0.000922	0.0742	CbGeAlD
Quinapril—SLC15A2—respiratory system—chronic obstructive pulmonary disease	0.000913	0.0735	CbGeAlD
Quinapril—ACE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000843	0.0679	CbGeAlD
Quinapril—SLC15A2—bronchus—chronic obstructive pulmonary disease	0.000751	0.0605	CbGeAlD
Quinapril—SLC15A2—trachea—chronic obstructive pulmonary disease	0.000675	0.0543	CbGeAlD
Quinapril—ACE—lung—chronic obstructive pulmonary disease	0.000556	0.0448	CbGeAlD
Quinapril—Perindopril—ACE—chronic obstructive pulmonary disease	0.000511	0.114	CrCbGaD
Quinapril—Spirapril—ACE—chronic obstructive pulmonary disease	0.000505	0.113	CrCbGaD
Quinapril—SLC15A2—lung—chronic obstructive pulmonary disease	0.000485	0.039	CbGeAlD
Quinapril—Moexipril—ACE—chronic obstructive pulmonary disease	0.000484	0.108	CrCbGaD
Quinapril—Lisinopril—ACE—chronic obstructive pulmonary disease	0.00045	0.1	CrCbGaD
Quinapril—Cilazapril—ACE—chronic obstructive pulmonary disease	0.00045	0.1	CrCbGaD
Quinapril—Ramipril—ACE—chronic obstructive pulmonary disease	0.000436	0.0973	CrCbGaD
Quinapril—Trandolapril—ACE—chronic obstructive pulmonary disease	0.000436	0.0973	CrCbGaD
Quinapril—Benazepril—ACE—chronic obstructive pulmonary disease	0.000392	0.0874	CrCbGaD
Quinapril—Enalapril—ACE—chronic obstructive pulmonary disease	0.000331	0.0738	CrCbGaD
Quinapril—Labetalol—ADRB2—chronic obstructive pulmonary disease	0.000298	0.0665	CrCbGaD
Quinapril—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.00245	CcSEcCtD
Quinapril—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000289	0.00244	CcSEcCtD
Quinapril—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.00244	CcSEcCtD
Quinapril—Tension—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.00244	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000287	0.00242	CcSEcCtD
Quinapril—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.000286	0.00241	CcSEcCtD
Quinapril—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000285	0.00241	CcSEcCtD
Quinapril—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.0024	CcSEcCtD
Quinapril—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000285	0.0024	CcSEcCtD
Quinapril—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000285	0.0024	CcSEcCtD
Quinapril—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000283	0.00239	CcSEcCtD
Quinapril—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000281	0.00237	CcSEcCtD
Quinapril—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000281	0.00237	CcSEcCtD
Quinapril—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00236	CcSEcCtD
Quinapril—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000278	0.00234	CcSEcCtD
Quinapril—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000276	0.00233	CcSEcCtD
Quinapril—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000276	0.00233	CcSEcCtD
Quinapril—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000273	0.00231	CcSEcCtD
Quinapril—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.00231	CcSEcCtD
Quinapril—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000272	0.0023	CcSEcCtD
Quinapril—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000272	0.0023	CcSEcCtD
Quinapril—Cough—Formoterol—chronic obstructive pulmonary disease	0.000272	0.0023	CcSEcCtD
Quinapril—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.00027	0.00228	CcSEcCtD
Quinapril—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00027	0.00228	CcSEcCtD
Quinapril—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.00227	CcSEcCtD
Quinapril—Cough—Montelukast—chronic obstructive pulmonary disease	0.000267	0.00225	CcSEcCtD
Quinapril—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000266	0.00224	CcSEcCtD
Quinapril—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000265	0.00224	CcSEcCtD
Quinapril—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000265	0.00223	CcSEcCtD
Quinapril—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000264	0.00223	CcSEcCtD
Quinapril—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.000264	0.00223	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000264	0.00223	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000264	0.00223	CcSEcCtD
Quinapril—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000262	0.00221	CcSEcCtD
Quinapril—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000262	0.00221	CcSEcCtD
Quinapril—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00026	0.0022	CcSEcCtD
Quinapril—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00219	CcSEcCtD
Quinapril—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00026	0.00219	CcSEcCtD
Quinapril—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00026	0.00219	CcSEcCtD
Quinapril—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00026	0.00219	CcSEcCtD
Quinapril—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.000259	0.00218	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000258	0.00218	CcSEcCtD
Quinapril—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000258	0.00218	CcSEcCtD
Quinapril—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000257	0.00217	CcSEcCtD
Quinapril—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00215	CcSEcCtD
Quinapril—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000254	0.00215	CcSEcCtD
Quinapril—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00215	CcSEcCtD
Quinapril—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000254	0.00215	CcSEcCtD
Quinapril—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000253	0.00213	CcSEcCtD
Quinapril—Infection—Formoterol—chronic obstructive pulmonary disease	0.000253	0.00213	CcSEcCtD
Quinapril—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00212	CcSEcCtD
Quinapril—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00212	CcSEcCtD
Quinapril—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000251	0.00212	CcSEcCtD
Quinapril—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00025	0.00211	CcSEcCtD
Quinapril—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00025	0.00211	CcSEcCtD
Quinapril—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000249	0.0021	CcSEcCtD
Quinapril—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000249	0.0021	CcSEcCtD
Quinapril—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000249	0.0021	CcSEcCtD
Quinapril—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000248	0.0021	CcSEcCtD
Quinapril—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000248	0.0021	CcSEcCtD
Quinapril—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000248	0.00209	CcSEcCtD
Quinapril—Infection—Montelukast—chronic obstructive pulmonary disease	0.000248	0.00209	CcSEcCtD
Quinapril—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000247	0.00209	CcSEcCtD
Quinapril—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000247	0.00209	CcSEcCtD
Quinapril—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000245	0.00207	CcSEcCtD
Quinapril—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00206	CcSEcCtD
Quinapril—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000244	0.00206	CcSEcCtD
Quinapril—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000242	0.00204	CcSEcCtD
Quinapril—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00203	CcSEcCtD
Quinapril—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00024	0.00203	CcSEcCtD
Quinapril—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000239	0.00201	CcSEcCtD
Quinapril—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000238	0.00201	CcSEcCtD
Quinapril—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000237	0.002	CcSEcCtD
Quinapril—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.002	CcSEcCtD
Quinapril—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.00199	CcSEcCtD
Quinapril—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000236	0.00199	CcSEcCtD
Quinapril—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000235	0.00198	CcSEcCtD
Quinapril—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000233	0.00197	CcSEcCtD
Quinapril—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000232	0.00196	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000232	0.00196	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000232	0.00196	CcSEcCtD
Quinapril—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00023	0.00194	CcSEcCtD
Quinapril—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00023	0.00194	CcSEcCtD
Quinapril—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000229	0.00193	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000227	0.00192	CcSEcCtD
Quinapril—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000227	0.00192	CcSEcCtD
Quinapril—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000227	0.00192	CcSEcCtD
Quinapril—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00191	CcSEcCtD
Quinapril—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00191	CcSEcCtD
Quinapril—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000225	0.0019	CcSEcCtD
Quinapril—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000224	0.00189	CcSEcCtD
Quinapril—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000224	0.00189	CcSEcCtD
Quinapril—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000224	0.00189	CcSEcCtD
Quinapril—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000223	0.00188	CcSEcCtD
Quinapril—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00187	CcSEcCtD
Quinapril—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000221	0.00187	CcSEcCtD
Quinapril—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00022	0.00185	CcSEcCtD
Quinapril—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00022	0.00185	CcSEcCtD
Quinapril—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Quinapril—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Quinapril—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00185	CcSEcCtD
Quinapril—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00184	CcSEcCtD
Quinapril—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00184	CcSEcCtD
Quinapril—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000217	0.00183	CcSEcCtD
Quinapril—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000216	0.00182	CcSEcCtD
Quinapril—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00182	CcSEcCtD
Quinapril—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000215	0.00181	CcSEcCtD
Quinapril—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00181	CcSEcCtD
Quinapril—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.0018	CcSEcCtD
Quinapril—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000213	0.0018	CcSEcCtD
Quinapril—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000213	0.00179	CcSEcCtD
Quinapril—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Quinapril—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000212	0.00179	CcSEcCtD
Quinapril—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00178	CcSEcCtD
Quinapril—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000211	0.00178	CcSEcCtD
Quinapril—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Quinapril—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00021	0.00177	CcSEcCtD
Quinapril—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000209	0.00177	CcSEcCtD
Quinapril—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000209	0.00176	CcSEcCtD
Quinapril—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000208	0.00176	CcSEcCtD
Quinapril—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000208	0.00176	CcSEcCtD
Quinapril—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00175	CcSEcCtD
Quinapril—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000207	0.00175	CcSEcCtD
Quinapril—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000205	0.00173	CcSEcCtD
Quinapril—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000204	0.00172	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00172	CcSEcCtD
Quinapril—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000201	0.0017	CcSEcCtD
Quinapril—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000201	0.0017	CcSEcCtD
Quinapril—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0002	0.00169	CcSEcCtD
Quinapril—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Quinapril—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Quinapril—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000199	0.00168	CcSEcCtD
Quinapril—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000198	0.00167	CcSEcCtD
Quinapril—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000198	0.00167	CcSEcCtD
Quinapril—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000197	0.00166	CcSEcCtD
Quinapril—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000196	0.00166	CcSEcCtD
Quinapril—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00019	0.0016	CcSEcCtD
Quinapril—Propafenone—CYP1A2—chronic obstructive pulmonary disease	0.000188	0.042	CrCbGaD
Quinapril—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000187	0.00158	CcSEcCtD
Quinapril—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000183	0.00154	CcSEcCtD
Quinapril—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000183	0.00154	CcSEcCtD
Quinapril—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00018	0.00152	CcSEcCtD
Quinapril—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00018	0.00152	CcSEcCtD
Quinapril—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000179	0.00151	CcSEcCtD
Quinapril—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000176	0.00149	CcSEcCtD
Quinapril—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00147	CcSEcCtD
Quinapril—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00147	CcSEcCtD
Quinapril—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000173	0.00146	CcSEcCtD
Quinapril—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000173	0.00146	CcSEcCtD
Quinapril—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000172	0.00146	CcSEcCtD
Quinapril—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00145	CcSEcCtD
Quinapril—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00144	CcSEcCtD
Quinapril—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00017	0.00143	CcSEcCtD
Quinapril—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000168	0.00142	CcSEcCtD
Quinapril—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000168	0.00142	CcSEcCtD
Quinapril—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000165	0.00139	CcSEcCtD
Quinapril—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00139	CcSEcCtD
Quinapril—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00137	CcSEcCtD
Quinapril—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000162	0.00137	CcSEcCtD
Quinapril—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000162	0.00137	CcSEcCtD
Quinapril—Rash—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00135	CcSEcCtD
Quinapril—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00135	CcSEcCtD
Quinapril—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00016	0.00135	CcSEcCtD
Quinapril—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00016	0.00135	CcSEcCtD
Quinapril—Headache—Formoterol—chronic obstructive pulmonary disease	0.000159	0.00135	CcSEcCtD
Quinapril—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000159	0.00135	CcSEcCtD
Quinapril—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000159	0.00134	CcSEcCtD
Quinapril—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000158	0.00134	CcSEcCtD
Quinapril—Rash—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00133	CcSEcCtD
Quinapril—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000157	0.00133	CcSEcCtD
Quinapril—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000157	0.00132	CcSEcCtD
Quinapril—Depression—Prednisone—chronic obstructive pulmonary disease	0.000157	0.00132	CcSEcCtD
Quinapril—Headache—Montelukast—chronic obstructive pulmonary disease	0.000156	0.00132	CcSEcCtD
Quinapril—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000155	0.00131	CcSEcCtD
Quinapril—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.0013	CcSEcCtD
Quinapril—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000154	0.0013	CcSEcCtD
Quinapril—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000153	0.00129	CcSEcCtD
Quinapril—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00129	CcSEcCtD
Quinapril—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000152	0.00128	CcSEcCtD
Quinapril—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.00128	CcSEcCtD
Quinapril—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000151	0.00128	CcSEcCtD
Quinapril—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00128	CcSEcCtD
Quinapril—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000151	0.00128	CcSEcCtD
Quinapril—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000151	0.00128	CcSEcCtD
Quinapril—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000151	0.00127	CcSEcCtD
Quinapril—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000148	0.00125	CcSEcCtD
Quinapril—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000148	0.00125	CcSEcCtD
Quinapril—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.0012	CcSEcCtD
Quinapril—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000142	0.0012	CcSEcCtD
Quinapril—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000139	0.00117	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Quinapril—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000138	0.00116	CcSEcCtD
Quinapril—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000136	0.00114	CcSEcCtD
Quinapril—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000135	0.00114	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000133	0.00112	CcSEcCtD
Quinapril—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000132	0.00111	CcSEcCtD
Quinapril—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000128	0.00108	CcSEcCtD
Quinapril—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000127	0.00107	CcSEcCtD
Quinapril—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000126	0.00106	CcSEcCtD
Quinapril—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000125	0.00105	CcSEcCtD
Quinapril—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000125	0.00105	CcSEcCtD
Quinapril—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000124	0.00104	CcSEcCtD
Quinapril—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000124	0.00104	CcSEcCtD
Quinapril—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000961	CcSEcCtD
Quinapril—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000959	CcSEcCtD
Quinapril—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000946	CcSEcCtD
Quinapril—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000934	CcSEcCtD
Quinapril—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000931	CcSEcCtD
Quinapril—Syncope—Prednisone—chronic obstructive pulmonary disease	0.00011	0.000929	CcSEcCtD
Quinapril—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000108	0.00091	CcSEcCtD
Quinapril—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000882	CcSEcCtD
Quinapril—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000882	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000104	0.000876	CcSEcCtD
Quinapril—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000103	0.000871	CcSEcCtD
Quinapril—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000845	CcSEcCtD
Quinapril—Oedema—Prednisone—chronic obstructive pulmonary disease	0.0001	0.000845	CcSEcCtD
Quinapril—Infection—Prednisone—chronic obstructive pulmonary disease	9.95e-05	0.00084	CcSEcCtD
Quinapril—Shock—Prednisone—chronic obstructive pulmonary disease	9.85e-05	0.000832	CcSEcCtD
Quinapril—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	9.82e-05	0.000829	CcSEcCtD
Quinapril—Tachycardia—Prednisone—chronic obstructive pulmonary disease	9.77e-05	0.000825	CcSEcCtD
Quinapril—Skin disorder—Prednisone—chronic obstructive pulmonary disease	9.73e-05	0.000821	CcSEcCtD
Quinapril—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	9.68e-05	0.000817	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	9.12e-05	0.00077	CcSEcCtD
Quinapril—Dizziness—Prednisolone—chronic obstructive pulmonary disease	9.11e-05	0.000769	CcSEcCtD
Quinapril—Insomnia—Prednisone—chronic obstructive pulmonary disease	9.06e-05	0.000765	CcSEcCtD
Quinapril—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	8.99e-05	0.000759	CcSEcCtD
Quinapril—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	8.82e-05	0.000744	CcSEcCtD
Quinapril—Rash—Prednisolone—chronic obstructive pulmonary disease	8.69e-05	0.000733	CcSEcCtD
Quinapril—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	8.68e-05	0.000733	CcSEcCtD
Quinapril—Fatigue—Prednisone—chronic obstructive pulmonary disease	8.63e-05	0.000729	CcSEcCtD
Quinapril—Headache—Prednisolone—chronic obstructive pulmonary disease	8.63e-05	0.000729	CcSEcCtD
Quinapril—Constipation—Prednisone—chronic obstructive pulmonary disease	8.56e-05	0.000723	CcSEcCtD
Quinapril—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	8.25e-05	0.000697	CcSEcCtD
Quinapril—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	8.19e-05	0.000691	CcSEcCtD
Quinapril—Nausea—Prednisolone—chronic obstructive pulmonary disease	8.19e-05	0.000691	CcSEcCtD
Quinapril—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	7.92e-05	0.000668	CcSEcCtD
Quinapril—Asthenia—Prednisone—chronic obstructive pulmonary disease	7.19e-05	0.000606	CcSEcCtD
Quinapril—Pruritus—Prednisone—chronic obstructive pulmonary disease	7.09e-05	0.000598	CcSEcCtD
Quinapril—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	6.85e-05	0.000578	CcSEcCtD
Quinapril—Dizziness—Prednisone—chronic obstructive pulmonary disease	6.62e-05	0.000559	CcSEcCtD
Quinapril—Vomiting—Prednisone—chronic obstructive pulmonary disease	6.37e-05	0.000537	CcSEcCtD
Quinapril—Rash—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000533	CcSEcCtD
Quinapril—Dermatitis—Prednisone—chronic obstructive pulmonary disease	6.31e-05	0.000532	CcSEcCtD
Quinapril—Headache—Prednisone—chronic obstructive pulmonary disease	6.27e-05	0.00053	CcSEcCtD
Quinapril—Nausea—Prednisone—chronic obstructive pulmonary disease	5.95e-05	0.000502	CcSEcCtD
